Pluribus Labs’s Bio-Techne TECH Stock Holding History

Pluribus Labs’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,212	Closed	-$415K	–	205
2021 Q4	$415K	Buy	+3,212	New	+$394K	0.44%	70

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Pluribus Labs's TECH Position: Q1 2022 in Review

Pluribus Labs sold out of Bio-Techne (TECH) in Q1 2022, closing a stake of 3,212 shares — an estimated $415K sold.

Pluribus Labs first reported a position in TECH in Q4 2021 and held it in 1 quarter. The position peaked at $415K in Q4 2021. 556 funds tracked by Wall St. Rank hold TECH as of Q1 2022.

Pluribus Labs reported no remaining Bio-Techne position as of Q1 2022 after selling out during the quarter.
Pluribus Labs sold 3,212 Bio-Techne shares in Q1 2022, an estimated $415K.
Pluribus Labs first reported a position in Bio-Techne in Q4 2021 and held it in 1 quarter.
Pluribus Labs's Bio-Techne position peaked at $415K in Q4 2021.
556 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2022.

Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.